Back to Journals » Cancer Management and Research » Volume 13

LncRNA PTCSC3 and lncRNA HULC Negatively Affect Each Other to Regulate Cancer Cell Invasion and Migration in Gastric Cancer [Retraction]

Authors Cai Y, Li Y, Sun B, Wang H, Zhang W, Zhao Y, Zhao H, Zhang J, Xu J, Wang Y

Received 18 October 2021

Accepted for publication 18 October 2021

Published 21 October 2021 Volume 2021:13 Pages 8003—8004

DOI https://doi.org/10.2147/CMAR.S344967



Cai Y, Li Y, Sun B, et al. Cancer Manag Res. 2020;12:8535–8543.

The Editor and Publisher of Cancer Management and Research wish to retract the published article. Concerns were raised regarding the alleged duplication of images in Figure 4, specifically:

  • Figure 4A panel SNU-1 PTCSC3+HULC siRNA appears to have been duplicated with Figure 4A panel AGS PTCSC3+HULC siRNA.
  • Figure 4B panels 0h PTCSC3, HULU, PTCSC3+HLUC and PTCSC3+HLUC siRNA all appear to be duplicates of each other.

The authors were unable to provide a satisfactory explanation for the alleged duplication and could not provide satisfactory original data for their study. The Editor advised for the article to be retracted and the authors agreed with this decision.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.

This retraction relates to this paper

Creative Commons License © 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.